Receipt of in-principal approval of Right Issue of equity shares of face value of Rs.10 each and issuing of amount aggregating not less than Rs.36,00,00,000.
Shukra Pharmaceuticals Ltd. Press Release Nov 29 2024
Filed with BSE ·
6ix hasn’t read this filing yet.
Shukra Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Shukra Pharmaceuticals
- Shukra Pharmaceuticals Ltd. Press Release Nov 14 2024
- Shukra Pharmaceuticals Ltd. Press Release Nov 07 2024
Later from Shukra Pharmaceuticals
- Shukra Pharmaceuticals Ltd. Press Release Dec 30 2024
- Shukra Pharmaceuticals Ltd. Press Release Jan 24 2025
- Shukra Pharmaceuticals Ltd. Press Release Jan 29 2025
- Shukra Pharmaceuticals Ltd. Press Release Feb 03 2025
- Shukra Pharmaceuticals Ltd. Press Release Feb 04 2025
Follow Shukra Pharmaceuticals into a list and get an email when it puts out news.
Follow Shukra Pharmaceuticals